Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
An estimated 170,000 people contract TB each year in Vietnam. The new e-LMIS system helps ensure a reliable drug supply for those who need treatment.
The COVID-19 pandemic placed extraordinary stress on the Kyrgyz Republic’s health system and health care providers, revealing the need for new approaches that would address the immediate needs brought on by the pandemic and contribute to the country’s health system resilience.
This report presents findings from December 2022 assessment of medical-grade liquid oxygen capabilities and availability for use in health facilities in the Kyrgyz Republic.
This brief presents work completed under the LHSS Kyrgyz Republic Activity Intervention 4: Enhance Cold Chain System. LHSS worked with key government stakeholders, including the Republican Center of Immunoprophylaxis, to digitalize and update components of the country’s vaccine registry and complement these updates by adding additional functionalities for cold chain tracking and management.
This Question-and-Answer (Q&A) document covers commonly asked questions and answers on TB exams, treatment, and reimbursement through Social Health Insurance (SHI). It provides guidance to TB treatment facilities as they integrate SHI and transition TB treatment services into SHI. The document also includes hyperlinks as additional reference sources for readers.
The Vietnam government transitions funding of TB treatment to the SHI fund with support from LHSS. This transition marks a critical milestone, ensuring uninterrupted access to life-saving treatment.
This fact sheet provides a summary of activity progress in Central Asia as well as results and impact.
Vietnam is one of the 30 countries with the highest burden of TB and drug-resistant TB in the world, with more than 172,000 cases and 10,400 deaths from TB in Vietnam in 2020 (WHO). On July 1, TB treatment facilities nationwide started providing TB drugs to patients through social health insurance, marking an important milestone for financial sustainability.
This rapid assessment aimed to determine which health facilities in seven high-TB burden provinces of Vietnam meet social health insurance (SHI) requirements for TB service provision and for reimbursement of TB services through the SHI scheme.
Lhss prepared this report, discussing procurement and payment considerations related to the transition of first-line tuberculosis (TB) drug procurement in Vietnam from the central state budget to the social health insurance fund starting in 2022.
LHSS Kyrgyz Team presents findings from August 2021 assessment of Kyrgyz Republic's state-run Laboratory for Virologic and Molecular Genetic Studies.
This assistance is provided under USAID’s Local Health System Sustainability program. Since the start of the coronavirus outbreak, USAID has provided more than $7 million USD to help the Kyrgyz Republic fight the COVID-19 pandemic.
LHSS worked from April 2020 to November 2022 to address the immediate needs of the Government of the Kyrgyz Republic related to prevention, detection, and response to the COVID-19 pandemic. This fact sheet summarizes focus areas, results, and impact.
This document provides a roadmap for Vietnam’s National Tuberculosis (TB) Program to transition procurement and payment for TB drugs to the country’s social health insurance scheme.